Central nervous system – multiple, unspecified molecular targets

The Central nervous system – multiple, unspecified molecular targets designation is a non-specific classification used to describe drugs or substances that act upon the brain and spinal cord without a single, clearly defined molecular target. This category often encompasses agents with polypharmacological profiles, where the therapeutic effect is the result of simultaneous interactions with various receptors, ion channels, and enzymes, or drugs whose exact mechanism of action remains elusive despite proven clinical efficacy (ChEMBL Database, 2024). Historically, many general anesthetics and early psychotropic medications were placed in this category because they appeared to alter the physical properties of neuronal membranes or modulate global neurotransmission rather than binding to a specific protein pocket (StatPearls, General Anesthesia, 2023). In modern drug discovery, this label is frequently used for complex mixtures, such as botanical extracts, or for compounds that demonstrate broad-spectrum activity across multiple CNS pathways. While these agents can be highly effective for conditions like epilepsy, chronic pain, or psychiatric disorders, the lack of a specific target poses significant challenges for rational drug design and the prediction of off-target side effects. Consequently, this term serves more as a functional or systemic descriptor than a molecular one, highlighting a gap in the current understanding of a drug's precise interactome within the nervous system (National Center for Biotechnology Information, 2024).

Other names

CNS targetsUnspecified CNS targetsMultiple CNS targetsNon-specific CNS targetsCentral nervous system (organism-level target)

Non-specific modulation of neuronal excitability, membrane fluidity alterations, or simultaneous interaction with multiple neurotransmitter systems and ion channels.